NasdaqGS - Nasdaq Real Time Price USD
Insmed Incorporated (INSM)
67.92
-0.21
(-0.30%)
As of 1:14:42 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 13 |
| Avg. Estimate | -1.31 | -1.37 | -5.16 | -3.56 |
| Low Estimate | -1.46 | -1.53 | -5.82 | -5.11 |
| High Estimate | -1.2 | -1.24 | -3.79 | -2.33 |
| Year Ago EPS | -1.94 | -1.27 | -5.57 | -5.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 19 | 18 |
| Avg. Estimate | 103.37M | 113.77M | 466.71M | 993.81M |
| Low Estimate | 98.7M | 108.5M | 441.1M | 845.97M |
| High Estimate | 107M | 118.44M | 512.3M | 1.41B |
| Year Ago Sales | 90.34M | 93.42M | 363.71M | 466.71M |
| Sales Growth (year/est) | 14.42% | 21.78% | 28.32% | 112.94% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.23 | -1.25 | -1.16 | -1.36 |
| EPS Actual | -1.94 | -1.27 | -1.32 | -1.42 |
| Difference | -0.71 | -0.02 | -0.16 | -0.06 |
| Surprise % | -58.20% | -1.91% | -13.32% | -4.22% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.31 | -1.37 | -5.16 | -3.56 |
| 7 Days Ago | -1.31 | -1.36 | -5.09 | -3.57 |
| 30 Days Ago | -1.37 | -1.4 | -5.31 | -3.52 |
| 60 Days Ago | -1.37 | -1.4 | -5.34 | -3.53 |
| 90 Days Ago | -1.34 | -1.27 | -4.47 | -2.46 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 1 | 1 |
| Up Last 30 Days | 6 | 5 | 5 | 4 |
| Down Last 7 Days | 1 | 2 | 1 | 2 |
| Down Last 30 Days | 3 | 5 | 6 | 7 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INSM | 32.34% | -7.62% | 7.28% | 31.04% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 5/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/12/2025 |
| Maintains | UBS: Buy to Buy | 5/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/22/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/20/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 3/19/2025 |
Related Tickers
ALNY Alnylam Pharmaceuticals, Inc.
291.38
+2.13%
CYTK Cytokinetics, Incorporated
31.00
-0.02%
BBIO BridgeBio Pharma, Inc.
33.17
-1.98%
ARGX argenx SE
571.65
+1.06%
ACLX Arcellx, Inc.
57.91
-1.48%
IONS Ionis Pharmaceuticals, Inc.
33.74
+0.52%
MRUS Merus N.V.
41.25
-0.75%
ASND Ascendis Pharma A/S
157.84
+0.15%
PCVX Vaxcyte, Inc.
32.17
+1.00%
CRNX Crinetics Pharmaceuticals, Inc.
30.99
-0.80%